INTEGRA LIFESCIENCES HOLDINGS CORP Current Liabilities
INTEGRA LIFESCIENCES HOLDINGS CORP (IART) had Current Liabilities of $330.88 million as of 2026-06-30, per its 10-Q filed 2026-07-29.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-07-29
- 2026-06-30: Liabilities, Current $330.88M.
- 2026-03-31: Liabilities, Current $346.85M.
- 2025-12-31: Liabilities, Current $455.98M.
- 2025-09-30: Liabilities, Current $364.05M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-06-30 | $330.88M 10-Q · filed 2026-07-29 | |
| 2026-03-31 | $346.85M 10-Q · filed 2026-05-05 | |
| 2025-12-31 | $455.98M 10-Q · filed 2026-07-29 | |
| 2025-09-30 | $364.05M 10-Q · filed 2025-10-30 | |
| 2025-06-30 | $929.81M 10-Q · filed 2025-07-31 | |
| 2025-03-31 | $918.45M 10-Q · filed 2025-05-05 | |
| 2024-12-31 | $922.13M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $912.56M 10-Q · filed 2024-11-04 | |
| 2024-06-30 | $328.32M 10-Q · filed 2024-07-29 | |
| 2024-03-31 | $302.39M 10-Q · filed 2024-05-06 | |
| 2023-12-31 | $306.98M 10-K · filed 2025-02-25 | |
| 2023-09-30 | $355.71M 10-Q · filed 2023-10-25 | |
| 2023-06-30 | $377.50M 10-Q · filed 2023-07-27 | |
| 2023-03-31 | $282.29M 10-Q · filed 2023-04-26 | |
| 2022-12-31 | $320.91M 10-K · filed 2024-02-28 | |
| 2022-09-30 | $304.45M 10-Q · filed 2022-10-26 | |
| 2022-06-30 | $295.60M 10-Q · filed 2022-07-27 | |
| 2022-03-31 | $315.83M 10-Q · filed 2022-04-27 | |
| 2021-12-31 | $340.02M 10-K · filed 2023-02-22 | |
| 2021-09-30 | $332.86M 10-Q · filed 2021-11-02 | |
| 2021-06-30 | $318.76M 10-Q · filed 2021-07-29 | |
| 2021-03-31 | $412.30M 10-Q · filed 2021-04-29 | |
| 2020-12-31 | $401.01M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $255.15M 10-Q · filed 2020-10-29 | |
| 2020-06-30 | $212.41M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $246.49M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $331.31M 10-K · filed 2021-02-23 | |
| 2019-09-30 | $302.64M 10-Q · filed 2019-10-25 | |
| 2019-06-30 | $315.11M 10-Q · filed 2019-07-25 | |
| 2019-03-31 | $288.11M 10-Q · filed 2019-04-29 | |
| 2018-12-31 | $262.55M 10-K · filed 2020-02-21 | |
| 2018-09-30 | $258.34M 10-Q · filed 2018-11-01 | |
| 2018-06-30 | $233.34M 10-Q · filed 2018-07-26 | |
| 2018-03-31 | $336.02M 10-Q · filed 2018-04-26 | |
| 2017-12-31 | $348.91M 10-K · filed 2019-02-26 | |
| 2017-09-30 | $210.23M 10-Q · filed 2017-10-26 | |
| 2017-06-30 | $177.88M 10-Q · filed 2017-07-26 | |
| 2017-03-31 | $188.08M 10-Q · filed 2017-04-26 | |
| 2016-12-31 | $123.60M 10-K · filed 2018-03-01 | |
| 2016-09-30 | $161.40M 10-Q · filed 2016-10-28 | |
| 2016-06-30 | $149.83M 10-Q · filed 2016-07-28 | |
| 2016-03-31 | $156.63M 10-Q · filed 2016-04-27 | |
| 2015-12-31 | $139.13M 10-K · filed 2017-02-23 | |
| 2015-09-30 | $139.95M 10-Q · filed 2015-11-04 | |
| 2015-06-30 | $155.75M 10-Q · filed 2015-07-31 | |
| 2015-03-31 | $126.81M 10-Q · filed 2015-05-01 | |
| 2014-12-31 | $126.03M 10-K · filed 2016-02-26 | |
| 2014-09-30 | $130.12M 10-Q · filed 2014-11-07 | |
| 2014-06-30 | $126.90M 10-Q · filed 2014-08-05 | |
| 2014-03-31 | $116.83M 10-Q · filed 2014-05-01 | |
| 2013-12-31 | $119.38M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $122.28M 10-Q · filed 2013-10-30 | |
| 2013-06-30 | $109.34M 10-Q/A · filed 2013-08-02 | |
| 2013-03-31 | $105.78M 10-Q · filed 2013-05-02 | |
| 2012-12-31 | $106.93M 8-K · filed 2014-06-20 | |
| 2012-09-30 | $112.57M 10-Q · filed 2012-10-24 | |
| 2012-06-30 | $112.25M 10-Q · filed 2012-07-31 | |
| 2012-03-31 | $104.59M 10-Q · filed 2012-04-26 | |
| 2011-12-31 | $101.87M 10-K · filed 2013-02-26 | |
| 2011-09-30 | $104.43M 10-Q · filed 2011-10-31 | |
| 2011-06-30 | $118.01M 10-Q · filed 2011-08-01 | |
| 2011-03-31 | $163.32M 10-Q · filed 2011-04-28 | |
| 2010-12-31 | $201.86M 10-K · filed 2012-02-27 | $200.03M 10-K · filed 2011-02-24 |
| 2010-09-30 | $102.70M 10-Q · filed 2010-10-28 | |
| 2010-06-30 | $85.64M 10-Q · filed 2010-07-29 | |
| 2009-12-31 | $156.73M 10-K · filed 2011-02-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |
| Beta Bionics, Inc. (BBNX) | United States | $0.979B | -9.66 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| SpyGlass Pharma, Inc. (SGP) | United States | $0.925B | |
| SI-BONE, Inc. (SIBN) | United States | $0.830B | -49.82 |
| MIMEDX GROUP, INC. (MDXG) | United States | $0.687B | 89.92 |